Prevention of coronary in-stent restenosis and vein graft failure: Does vascular gene therapy have a role?

Pharmacology and Therapeutics

Volumn 136, Issue 1, 2012, Pages 23-34

  Robertson, Keith E ^a,b   McDonald, Robert A ^a   Oldroyd, Keith G ^b   Nicklin, Stuart A ^a   Baker, Andrew H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

Coronary artery bypass; Gene therapy; In stent restenosis; Vein graft failure

Indexed keywords

ADENOVIRUS VECTOR; BOVINE PANCREAS TRYPSIN INHIBITOR; EXTRACELLULAR SUPEROXIDE DISMUTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LENTIVIRUS VECTOR; MYC PROTEIN; NUCLEAR PROTEIN; PARVOVIRUS VECTOR; PLACEBO; PLATELET DERIVED GROWTH FACTOR; PROTEIN 35K; THROMBOMODULIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR E2F; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN;

ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; DRUG MECHANISM; EXTRACELLULAR MATRIX; GENE TARGETING; GENE THERAPY; IN-STENT RESTENOSIS; NEOINTIMA; NEOINTIMAL HYPERPLASIA; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; THROMBOSIS; VASCULAR ENDOTHELIUM; VEIN GRAFT DISEASE;

ADENOVIRIDAE; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CLINICAL TRIALS AS TOPIC; CORONARY RESTENOSIS; DEPENDOVIRUS; ENDOTHELIUM, VASCULAR; GENETIC THERAPY; HUMANS; LENTIVIRUS; NEOINTIMA; RETROVIRIDAE; STENTS; VEINS;

EID: 84865598838     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.07.002     Document Type: Review

References (163)

1. Y.S. Ahi, D.S. Bangari, and S.K. Mittal Adenoviral vector immunity: its implications and circumvention strategies Curr Gene Ther 11 2011 307 320
2. E.F. Akowuah, C. Gray, A. Lawrie, P.J. Sheridan, C.H. Su, and T. Bettinger Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model Gene Ther 12 2005 1154 1157 (Pubitemid 41030621)
3. R. Alba, A.C. Bradshaw, L. Coughlan, L. Denby, R.A. McDonald, and S.N. Waddington Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors Blood 116 2010 2656 2664
4. R. Alemany, and D.T. Curiel CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors Gene Ther 8 2001 1347 1353 (Pubitemid 32834304)
5. J.H. Alexander, T.B. Ferguson Jr., D.M. Joseph, M.J. Mack, R.K. Wolf, and C.M. Gibson The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics Am Heart J 150 2005 643 649 (Pubitemid 41396491)
6. J.H. Alexander, G. Hafley, R.A. Harrington, E.D. Peterson, T.B. Ferguson Jr., and T.J. Lorenz Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454 (Pubitemid 41627922)
7. Z.A. Ali, N.J. Alp, H. Lupton, N. Arnold, T. Bannister, and Y. Hu Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting Arterioscler Thromb Vasc Biol 27 2007 833 840 (Pubitemid 46606714)
8. Z.A. Ali, C.A. Bursill, Y. Hu, R.P. Choudhury, Q. Xu, and D.R. Greaves Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice Circulation 112 2005 I235 241
9. E. Allaire, and A.W. Clowes Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response Ann Thorac Surg 63 1997 582 591 (Pubitemid 27084610)
10. G.D. Angelini, A.J. Bryan, H.M. Williams, R. Morgan, and A.C. Newby Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts J Thorac Cardiovasc Surg 99 1990 433 439 (Pubitemid 20097769)
11. T. Asahara, D. Chen, Y. Tsurumi, M. Kearney, S. Rossow, and J. Passeri Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer Circulation 94 1996 3291 3302
12. A.H. Baker Gene therapy for bypass graft failure and restenosis Pathophysiol Haemost Thromb 32 2002 389 391 (Pubitemid 37490578)
13. A.H. Baker, A.B. Zaltsman, S.J. George, and A.C. Newby Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis J Clin Invest 101 1998 1478 1487 (Pubitemid 28145266)
14. S. Bangalore, S. Kumar, M. Fusaro, N. Amoroso, M.J. Attubato, and F. Feit Short and Long-Term Outcomes with Drug Eluting and Bare Metal Coronary Stents: A Mixed Treatment Comparison Analysis of 117 762 Patient-Years of Follow-up from Randomized Trials Circulation 125 2012 2873 2891
15. H. Banno, Y. Takei, T. Muramatsu, K. Komori, and K. Kadomatsu Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts J Vasc Surg 44 2006 633 641 (Pubitemid 44293180)
16. J.M. Bergelson, J.A. Cunningham, G. Droguett, E.A. Kurt-Jones, A. Krithivas, and J.S. Hong Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 275 1997 1320 1323 (Pubitemid 27114163)
17. S. Bhardwaj, H. Roy, T. Heikura, and S. Yla-Herttuala VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries Eur J Clin Invest 35 2005 669 676 (Pubitemid 41640902)
18. S. Bhardwaj, H. Roy, and S. Yla-Herttuala Gene therapy to prevent occlusion of venous bypass grafts Expert Rev Cardiovasc Ther 6 2008 641 652
19. R.C. Carlisle, Y. Di, A.M. Cerny, A.F. Sonnen, R.B. Sim, and N.K. Green Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1 Blood 113 2009 1909 1918
20. D. Cefai, E. Simeoni, K.M. Ludunge, R. Driscoll, L.K. von Segesser, and L. Kappenberger Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo J Mol Cell Cardiol 38 2005 333 344 (Pubitemid 40215203)
21. J. Chamberlain, M. Wheatcroft, N. Arnold, H. Lupton, D.C. Crossman, and J. Gunn A novel mouse model of in situ stenting Cardiovasc Res 85 2010 38 44
22. S. Chen, M. Kapturczak, S.A. Loiler, S. Zolotukhin, O.Y. Glushakova, and K.M. Madsen Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors Hum Gene Ther 16 2005 235 247 (Pubitemid 40344215)
23. L. Cheng, G. Mantile, R. Pauly, C. Nater, A. Felici, and R. Monticone Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo Circulation 98 1998 2195 2201 (Pubitemid 28527480)
24. M.S. Conte, D.F. Bandyk, A.W. Clowes, G.L. Moneta, L. Seely, and T.J. Lorenz Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery J Vasc Surg 43 2006 742 751 (discussion 751)
25. V.R. Conti, and G.C. Hunter Gene therapy and vein graft patency in coronary artery bypass graft surgery JAMA 294 2005 2495 2497 (Pubitemid 41627929)
26. L. Coughlan, R. Alba, A.L. Parker, A.C. Bradshaw, I.A. McNeish, and S.A. Nicklin Tropism-modification strategies for targeted gene delivery using adenoviral vectors Viruses 2 2010 2290 2355
27. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
28. G. Dangas, and V. Fuster Management of restenosis after coronary intervention Am Heart J 132 1996 428 436 (Pubitemid 26292411)
29. L. Denby, S.A. Nicklin, and A.H. Baker Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation Gene Ther 12 2005 1534 1538 (Pubitemid 41508679)
30. N.C. Di Paolo, E.A. Miao, Y. Iwakura, K. Murali-Krishna, A. Aderem, and R.A. Flavell Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo Immunity 31 2009 110 121
31. D.A. Dichek, R.F. Neville, J.A. Zwiebel, S.M. Freeman, M.B. Leon, and W.F. Anderson Seeding of intravascular stents with genetically engineered endothelial cells Circulation 80 1989 1347 1353 (Pubitemid 19282525)
32. K.L. Dishart, L. Denby, S.J. George, S.A. Nicklin, S. Yendluri, and M.J. Tuerk Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy J Mol Cell Cardiol 35 2003 739 748 (Pubitemid 36773586)
33. D. Eefting, M.R. de Vries, J.M. Grimbergen, J.C. Karper, J.H. van Bockel, and P.H. Quax In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor J Vasc Surg 51 2010 429 437
34. D. Eefting, L. Seghers, J.M. Grimbergen, M.R. de Vries, H.C. de Boer, and J.W. Lardenoye A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease Cardiovasc Res 88 2010 367 375
35. K. Egashira, K. Nakano, K. Ohtani, K. Funakoshi, G. Zhao, and Y. Ihara Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys Arterioscler Thromb Vasc Biol 27 2007 2563 2568 (Pubitemid 350158906)
36. A. Ehsan, M.J. Mann, G. Dell'Acqua, and V.J. Dzau Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy J Thorac Cardiovasc Surg 121 2001 714 722
37. S. Elezi, A. Kastrati, J. Pache, A. Wehinger, M. Hadamitzky, and J. Dirschinger Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement J Am Coll Cardiol 32 1998 1866 1873 (Pubitemid 29010448)
38. I. Fishbein, I. Alferiev, M. Bakay, S.J. Stachelek, P. Sobolewski, and M. Lai Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries Circulation 117 2008 2096 2103 (Pubitemid 351572181)
39. I. Fishbein, I.S. Alferiev, O. Nyanguile, R. Gaster, J.M. Vohs, and G.S. Wong Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents Proc Natl Acad Sci U S A 103 2006 159 164 (Pubitemid 43076121)
40. R. Flynn, J.M. Buckler, C. Tang, F. Kim, and D.A. Dichek Helper-dependent adenoviral vectors are superior in vitro to first-generation vectors for endothelial cell-targeted gene therapy Mol Ther 18 2010 2121 2129
41. M.M. Gaffney, S.O. Hynes, F. Barry, and T. O'Brien Cardiovascular gene therapy: current status and therapeutic potential Br J Pharmacol 152 2007 175 188 (Pubitemid 47517600)
42. A. Gaggar, D.M. Shayakhmetov, and A. Lieber CD46 is a cellular receptor for group B adenoviruses Nat Med 9 2003 1408 1412 (Pubitemid 37466191)
43. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262 (Pubitemid 34633925)
44. S. Garg, and P. Serruys Benefits of and safety concerns associated with drug-eluting coronary stents Expert Rev Cardiovasc Ther 8 2010 449 470
45. S. Garg, and P.W. Serruys Coronary stents: current status J Am Coll Cardiol 56 2010 S1 42
46. R.L. Geary, J.K. Williams, D. Golden, D.G. Brown, M.E. Benjamin, and M.R. Adams Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis Arterioscler Thromb Vasc Biol 16 1996 34 43 (Pubitemid 26026929)
47. S.J. George, A.H. Baker, G.D. Angelini, and A.C. Newby Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins Gene Ther 5 1998 1552 1560 (Pubitemid 28517383)
48. S.J. George, K.M. Channon, and A.H. Baker Gene therapy and coronary artery bypass grafting: current perspectives Curr Opin Mol Ther 8 2006 288 294 (Pubitemid 44256362)
49. S.J. George, J.L. Johnson, G.D. Angelini, A.C. Newby, and A.H. Baker Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein Hum Gene Ther 9 1998 867 877 (Pubitemid 28197373)
50. S.J. George, C.T. Lloyd, G.D. Angelini, A.C. Newby, and A.H. Baker Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3 Circulation 101 2000 296 304 (Pubitemid 30054157)
51. S.J. George, S. Wan, J. Hu, R. MacDonald, J.L. Johnson, and A.H. Baker Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy Circulation 124 2011 S135 142
52. N.K. Green, C.W. Herbert, S.J. Hale, A.B. Hale, V. Mautner, and R. Harkins Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus Gene Ther 11 2004 1256 1263 (Pubitemid 39173432)
53. M. Grossman, S.E. Raper, K. Kozarsky, E.A. Stein, J.F. Engelhardt, and D. Muller Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia Nat Genet 6 1994 335 341 (Pubitemid 24190015)
54. A. Gruntzig Transluminal dilatation of coronary-artery stenosis Lancet 1 1978 263
55. R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein, and T. Finkel Efficient gene transfer into myocardium by direct injection of adenovirus vectors Circ Res 73 1993 1202 1207 (Pubitemid 23340215)
56. S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, and P. Leboulch LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419 (Pubitemid 37296260)
57. Z.C. Hartman, D.M. Appledorn, and A. Amalfitano Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications Virus Res 132 2008 1 14 (Pubitemid 351232078)
58. M. Hata, A. Sezai, T. Niino, M. Yoda, S. Wakui, and M. Chiku What is the optimal management for preventing saphenous vein graft diseases?: early results of intravascular angioscopic assessment Circ J 71 2007 286 287 (Pubitemid 46182707)
59. M. Hedman, J. Hartikainen, M. Syvanne, J. Stjernvall, A. Hedman, and A. Kivela Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) Circulation 107 2003 2677 2683 (Pubitemid 36667240)
60. M.O. Hiltunen, M. Laitinen, M.P. Turunen, M. Jeltsch, J. Hartikainen, and T.T. Rissanen Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta Circulation 102 2000 2262 2268
61. R. Hoffmann, G.S. Mintz, G.R. Dussaillant, J.J. Popma, A.D. Pichard, and L.F. Satler Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study Circulation 94 1996 1247 1254 (Pubitemid 26307249)
62. D.R. Holmes Jr., M. Savage, J.M. LaBlanche, L. Grip, P.W. Serruys, and P. Fitzgerald Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial Circulation 106 2002 1243 1250 (Pubitemid 34988643)
63. J.M. Isner Myocardial gene therapy Nature 415 2002 234 239 (Pubitemid 34059530)
64. M. Jessup, B. Greenberg, D. Mancini, T. Cappola, D.F. Pauly, and B. Jaski Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure Circulation 124 2011 304 313
65. B. Jiang, K. Qian, L. Du, I. Luttrell, K. Chitaley, and D.A. Dichek Helper-dependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteries Arterioscler Thromb Vasc Biol 31 2011 1317 1325
66. T.W. Johnson, Y.X. Wu, C. Herdeg, A. Baumbach, A.C. Newby, and K.R. Karsch Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries Arterioscler Thromb Vasc Biol 25 2005 754 759 (Pubitemid 40463865)
67. A. Jozkowicz, and J. Dulak Helper-dependent adenoviral vectors in experimental gene therapy Acta Biochim Pol 52 2005 589 599 (Pubitemid 41571704)
68. O. Kalyuzhniy, N.C. Di Paolo, M. Silvestry, S.E. Hofherr, M.A. Barry, and P.L. Stewart Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo Proc Natl Acad Sci U S A 105 2008 5483 5488 (Pubitemid 351753889)
69. A. Kass-Eisler, E. Falck-Pedersen, M. Alvira, J. Rivera, P.M. Buttrick, and B.A. Wittenberg Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo Proc Natl Acad Sci U S A 90 1993 11498 11502 (Pubitemid 24008666)
70. A. Kiang, Z.C. Hartman, R.S. Everett, D. Serra, H. Jiang, and M.M. Frank Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system Mol Ther 14 2006 588 598 (Pubitemid 44296088)
71. M.R. Kibbe, E. Tzeng, S.L. Gleixner, S.C. Watkins, I. Kovesdi, and A. Lizonova Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia J Vasc Surg 34 2001 156 165 (Pubitemid 33660705)
72. N. Kipshidze, P. Iversen, P. Overlie, T. Dunlap, B. Titus, and D. Lee First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study Cardiovasc Revasc Med 8 2007 230 235 (Pubitemid 350161452)
73. I. Kirby, E. Davison, A.J. Beavil, C.P. Soh, T.J. Wickham, and P.W. Roelvink Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein J Virol 74 2000 2804 2813 (Pubitemid 30117592)
74. B.D. Klugherz, P.L. Jones, X. Cui, W. Chen, N.F. Meneveau, and S. DeFelice Gene delivery from a DNA controlled-release stent in porcine coronary arteries Nat Biotechnol 18 2000 1181 1184
75. B.D. Klugherz, C. Song, S. DeFelice, X. Cui, Z. Lu, and J. Connolly Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus Hum Gene Ther 13 2002 443 454 (Pubitemid 34251509)
76. B. Koren, A. Weisz, L. Fischer, Z. Gluzman, M. Preis, and N. Avramovitch Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor Cardiovasc Revasc Med 7 2006 173 178 (Pubitemid 44292063)
77. R.G. Kratlian, and R.J. Hajjar Cardiac gene therapy: from concept to reality Curr Heart Fail Rep 9 2012 33 39
78. M.J. Kutryk, D.P. Foley, M. van den Brand, J.N. Hamburger, W.J. van der Giessen, and P.J. deFeyter Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial J Am Coll Cardiol 39 2002 281 287 (Pubitemid 34084634)
79. M. Laitinen, J. Hartikainen, M.O. Hiltunen, J. Eranen, M. Kiviniemi, and O. Narvanen Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty Hum Gene Ther 11 2000 263 270 (Pubitemid 30080384)
80. M. Laitinen, I. Zachary, G. Breier, T. Pakkanen, T. Hakkinen, and J. Luoma VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries Hum Gene Ther 8 1997 1737 1744 (Pubitemid 27488923)
81. C. Lebherz, G. Gao, J.P. Louboutin, J. Millar, D. Rader, and J.M. Wilson Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia J Gene Med 6 2004 663 672 (Pubitemid 40228082)
82. P. Libby, and E. Braunwald Braunwald's heart disease :a textbook of cardiovascular medicine 8th ed. 2008 Saunders/Elsevier Philadelphia
83. A. Lieber, C.Y. He, L. Meuse, D. Schowalter, I. Kirillova, and B. Winther The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors J Virol 71 1997 8798 8807 (Pubitemid 27446464)
84. Q. Liu, and D.A. Muruve Molecular basis of the inflammatory response to adenovirus vectors Gene Ther 10 2003 935 940 (Pubitemid 36722427)
85. R.D. Lopes, R.H. Mehta, G.E. Hafley, J.B. Williams, M.J. Mack, and E.D. Peterson Relationship Between Vein Graft Failure and Subsequent Clinical Outcomes After Coronary Artery Bypass Surgery Circulation 125 2012 749 756
86. M. Lyons, D. Onion, N.K. Green, K. Aslan, R. Rajaratnam, and M. Bazan-Peregrino Adenovirus type 5 interactions with human blood cells may compromise systemic delivery Mol Ther 14 2006 118 128 (Pubitemid 44191831)
87. M.J. Mann, G.H. Gibbons, R.S. Kernoff, F.P. Diet, P.S. Tsao, and J.P. Cooke Genetic engineering of vein grafts resistant to atherosclerosis Proc Natl Acad Sci U S A 92 1995 4502 4506
88. M.J. Mann, A.D. Whittemore, M.C. Donaldson, M. Belkin, M.S. Conte, and J.F. Polak Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Lancet 354 1999 1493 1498 (Pubitemid 29502101)
89. J. Mehilli, J. Pache, M. Abdel-Wahab, S. Schulz, R.A. Byrne, and K. Tiroch Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial Lancet 378 2011 1071 1078
90. R. Morishita, G.H. Gibbons, M. Horiuchi, K.E. Ellison, M. Nakama, and L. Zhang A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci U S A 92 1995 5855 5859
91. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, and C. O'Shaughnessy Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
92. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention Circulation 97 1998 916 931 (Pubitemid 28113931)
93. E.G. Nabel, G. Plautz, F.M. Boyce, J.C. Stanley, and G.J. Nabel Recombinant gene expression in vivo within endothelial cells of the arterial wall Science 244 1989 1342 1344 (Pubitemid 19170506)
94. S. Nayak, and R.W. Herzog Progress and prospects: immune responses to viral vectors Gene Ther 17 2010 295 304
95. S.A. Nicklin, H. Buening, K.L. Dishart, M. de Alwis, A. Girod, and U. Hacker Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells Mol Ther 4 2001 174 181 (Pubitemid 32851280)
96. C.G. Nicol, D. Graham, W.H. Miller, S.J. White, T.A. Smith, and S.A. Nicklin Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats Mol Ther 10 2004 344 354 (Pubitemid 39117879)
97. P. Nokisalmi, S. Pesonen, S. Escutenaire, M. Sarkioja, M. Raki, and V. Cerullo Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors Clin Cancer Res 16 2010 3035 3043
98. N. Ohno, H. Itoh, T. Ikeda, K. Ueyama, K. Yamahara, and K. Doi Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide Circulation 105 2002 1623 1626 (Pubitemid 34298601)
99. K. Oka, L. Pastore, I.H. Kim, A. Merched, S. Nomura, and H.J. Lee Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor Circulation 103 2001 1274 1281 (Pubitemid 32221352)
100. C.A. Pacak, C.S. Mah, B.D. Thattaliyath, T.J. Conlon, M.A. Lewis, and D.E. Cloutier Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo Circ Res 99 2006 e3 9
101. T.A. Painter Myointimal hyperplasia: pathogenesis and implications. 2. Animal injury models and mechanical factors Artif Organs 15 1991 103 118
102. J. Palomeque, E.R. Chemaly, P. Colosi, J.A. Wellman, S. Zhou, and F. Del Monte Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo Gene Ther 14 2007 989 997
103. C.J. Panetta, K. Miyauchi, D. Berry, R.D. Simari, D.R. Holmes, and R.S. Schwartz A tissue-engineered stent for cell-based vascular gene transfer Hum Gene Ther 13 2002 433 441 (Pubitemid 34251508)
104. P. Parang, and R. Arora Coronary vein graft disease: pathogenesis and prevention Can J Cardiol 25 2009 e57 62
105. A.L. Parker, S.N. Waddington, C.G. Nicol, D.M. Shayakhmetov, S.M. Buckley, and L. Denby Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes Blood 108 2006 2554 2561
106. S. Pesonen, P. Nokisalmi, S. Escutenaire, M. Sarkioja, M. Raki, and V. Cerullo Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors Gene Ther 17 2010 892 904
107. S. Peykar, D.J. Angiolillo, T.A. Bass, and M.A. Costa Saphenous vein graft disease Minerva Cardioangiol 52 2004 379 390 (Pubitemid 39457519)
108. S. Philippe, C. Sarkis, M. Barkats, H. Mammeri, C. Ladroue, and C. Petit Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo Proc Natl Acad Sci U S A 103 2006 17684 17689 (Pubitemid 44852220)
109. H.L. Puhakka, P. Turunen, M. Gruchala, C. Bursill, T. Heikura, and I. Vajanto Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits In Vivo 19 2005 515 521
110. Z. Qian, M. Haessler, J.A. Lemos, J.R. Arsenault, J.E. Aguirre, and J.R. Gilbert Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors Mol Ther 13 2006 694 704
111. G.N. Rao, and B.C. Berk Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression Circ Res 70 1992 593 599
112. S.E. Raper, N. Chirmule, F.S. Lee, N.A. Wivel, A. Bagg, and G.P. Gao Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer Mol Genet Metab 80 2003 148 158 (Pubitemid 37272241)
113. P.W. Roelvink, A. Lizonova, J.G. Lee, Y. Li, J.M. Bergelson, and R.W. Finberg The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F J Virol 72 1998 7909 7915 (Pubitemid 28421782)
114. A. Rosenzweig Vectors for cardiovascular gene therapy J Mol Cell Cardiol 35 2003 731 733 (Pubitemid 36773584)
115. J. Ruef, Z.Y. Hu, L.Y. Yin, Y. Wu, S.R. Hanson, and A.B. Kelly Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis Circ Res 81 1997 24 33 (Pubitemid 27272979)
116. J. Rutanen, A.M. Turunen, M. Teittinen, T.T. Rissanen, T. Heikura, and J.K. Koponen Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism Gene Ther 12 2005 980 987 (Pubitemid 40903420)
117. T. Schachner, G. Laufer, and J. Bonatti In vivo (animal) models of vein graft disease Eur J Cardiothorac Surg 30 2006 451 463 (Pubitemid 44192609)
118. A. Schepers, M.R. de Vries, C.J. van Leuven, J.M. Grimbergen, V.M. Holers, and M.R. Daha Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice Circulation 114 2006 2831 2838 (Pubitemid 46018286)
119. A. Schepers, D. Eefting, P.I. Bonta, J.M. Grimbergen, M.R. de Vries, and V. van Weel Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo Arterioscler Thromb Vasc Biol 26 2006 2063 2069 (Pubitemid 44253789)
120. R.S. Schwartz, N.A. Chronos, and R. Virmani Preclinical restenosis models and drug-eluting stents: still important, still much to learn J Am Coll Cardiol 44 2004 1373 1385 (Pubitemid 39303937)
121. E. Seiradake, D. Henaff, H. Wodrich, O. Billet, M. Perreau, and C. Hippert The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution PLoS Pathog 5 2009 e1000277
122. F. Sharif, K. Daly, J. Crowley, and T. O'Brien Current status of catheter- and stent-based gene therapy Cardiovasc Res 64 2004 208 216 (Pubitemid 39361681)
123. F. Sharif, S.O. Hynes, J. McMahon, R. Cooney, S. Conroy, and P. Dockery Gene-eluting stents: comparison of adenoviral and adeno- associated viral gene delivery to the blood vessel wall in vivo Hum Gene Ther 17 2006 741 750 (Pubitemid 44100719)
124. S. Sharma, C. Christopoulos, N. Kukreja, and D.A. Gorog Local drug delivery for percutaneous coronary intervention Pharmacol Ther 129 2011 260 266
125. E.V. Shashkova, K. Doronin, J.S. Senac, and M.A. Barry Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus Cancer Res 68 2008 5896 5904
126. D.M. Shayakhmetov, A.M. Eberly, Z.Y. Li, and A. Lieber Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs J Virol 79 2005 1053 1061 (Pubitemid 40053889)
127. D.M. Shayakhmetov, A. Gaggar, S. Ni, Z.Y. Li, and A. Lieber Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity J Virol 79 2005 7478 7491 (Pubitemid 40756784)
128. Y. Shi, J.E. O'Brien, A. Fard, J.D. Mannion, D. Wang, and A. Zalewski Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries Circulation 94 1996 1655 1664 (Pubitemid 26320272)
129. M. Shibata, H. Suzuki, M. Nakatani, S. Koba, E. Geshi, and T. Katagiri The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation Histochem Cell Biol 116 2001 471 481 (Pubitemid 34020482)
130. R.C. Siow, C.M. Mallawaarachchi, and P.L. Weissberg Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries Cardiovasc Res 59 2003 212 221 (Pubitemid 36776387)
131. J.E. Sousa, M.A. Costa, A. Abizaid, A.S. Abizaid, F. Feres, and I.M. Pinto Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study Circulation 103 2001 192 195 (Pubitemid 32095401)
132. M.D. Stachler, and J.S. Bartlett Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells Gene Ther 13 2006 926 931
133. D. Stone, Y. Liu, D. Shayakhmetov, Z.Y. Li, S. Ni, and A. Lieber Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver J Virol 81 2007 4866 4871 (Pubitemid 46668683)
134. N. Swanson, K. Hogrefe, Q. Javed, N. Malik, and A.H. Gershlick Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia J Invasive Cardiol 15 2003 688 692 (Pubitemid 37549285)
135. N. Tabuchi, M. Shichiri, A. Shibamiya, T. Koyama, F. Nakazawa, and J. Chung Non-viral in vivo thrombomodulin gene transfer prevents early loss of thromboresistance of grafted veins Eur J Cardiothorac Surg 26 2004 995 1001 (Pubitemid 39433885)
136. B. Thaci, I.V. Ulasov, D.A. Wainwright, and M.S. Lesniak The challenge for gene therapy: innate immune response to adenoviruses Oncotarget 2 2011 113 121
137. A.C. Thomas, M.J. Wyatt, and A.C. Newby Reduction of early vein graft thrombosis by tissue plasminogen activator gene transfer Thromb Haemost 102 2009 145 152
138. P. Turunen, H.L. Puhakka, T. Heikura, E. Romppanen, M. Inkala, and O. Leppanen Extracellular superoxide dismutase with vaccinia virus anti-inflammatory protein 35K or tissue inhibitor of metalloproteinase-1: Combination gene therapy in the treatment of vein graft stenosis in rabbits Hum Gene Ther 17 2006 405 414
139. E. Van Belle, L. Maillard, F.O. Tio, and J.M. Isner Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation Biochem Biophys Res Commun 235 1997 311 316 (Pubitemid 27313702)
140. E. Van Belle, F.O. Tio, T. Couffinhal, L. Maillard, J. Passeri, and J.M. Isner Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition Circulation 95 1997 438 448 (Pubitemid 27056212)
141. W.J. van der Giessen, A.M. Lincoff, R.S. Schwartz, H.M. van Beusekom, P.W. Serruys, and D.R. Holmes Jr. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 1996 1690 1697 (Pubitemid 26320276)
142. J. Vargas Jr., G.L. Gusella, V. Najfeld, M.E. Klotman, and A. Cara Novel integrase-defective lentiviral episomal vectors for gene transfer Hum Gene Ther 15 2004 361 372 (Pubitemid 38469778)
143. F. Vetrini, and P. Ng Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives Viruses 2 2010 1886 1917
144. F. Vigant, D. Descamps, B. Jullienne, S. Esselin, E. Connault, and P. Opolon Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver Mol Ther 16 2008 1474 1480
145. R. Virmani, A. Farb, G. Guagliumi, and F.D. Kolodgie Drug-eluting stents: caution and concerns for long-term outcome Coron Artery Dis 15 2004 313 318 (Pubitemid 39299245)
146. H.E. von der Leyen, A. Mugge, C. Hanefeld, C.W. Hamm, M. Rau, and H.J. Rupprecht A Prospective, Single-Blind, Multicenter, Dose Escalation Study of Intracoronary iNOS Lipoplex (CAR-MP583) Gene Therapy for the Prevention of Restenosis in Patients with de novo or Restenotic Coronary Artery Lesion (REGENT I Extension) Hum Gene Ther 22 2011 951 958
147. S.N. Waddington, J.H. McVey, D. Bhella, A.L. Parker, K. Barker, and H. Atoda Adenovirus serotype 5 hexon mediates liver gene transfer Cell 132 2008 397 409 (Pubitemid 351200513)
148. D.H. Walter, M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, and P.W. Stratford Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis Circulation 110 2004 36 45 (Pubitemid 38885702)
149. S. Wan, S.J. George, C. Berry, and A.H. Baker Vein graft failure: current clinical practice and potential for gene therapeutics Gene Ther 2012 1 7
150. S. Wan, S.J. George, C. Berry, and A.H. Baker Vein graft failure: current clinical practice and potential for gene therapeutics Gene Ther 19 2012 630 636
151. S. Wan, S.J. George, S.A. Nicklin, A.P. Yim, and A.H. Baker Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts Mol Ther 9 2004 689 698 (Pubitemid 38660422)
152. H. Wang, Z.Y. Li, Y. Liu, J. Persson, I. Beyer, and T. Moller Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14 Nat Med 17 2010 96 104
153. S. Wen, S. Graf, P.G. Massey, and D.A. Dichek Improved vascular gene transfer with a helper-dependent adenoviral vector Circulation 110 2004 1484 1491 (Pubitemid 39238028)
154. T.J. Wickham, P. Mathias, D.A. Cheresh, and G.R. Nemerow Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment Cell 73 1993 309 319 (Pubitemid 23123309)
155. R.L. Wilensky, J.F. Tanguay, S. Ito, A.L. Bartorelli, J. Moses, and D.O. Williams Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia Am Heart J 139 2000 1061 1070 (Pubitemid 30390337)
156. S. Worgall, G. Wolff, E. Falck-Pedersen, and R.G. Crystal Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration Hum Gene Ther 8 1997 37 44 (Pubitemid 27075341)
157. L.M. Work, H. Buning, E. Hunt, S.A. Nicklin, L. Denby, and N. Britton Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses Mol Ther 13 2006 683 693
158. L.M. Work, S.A. Nicklin, N.J. Brain, K.L. Dishart, D.J. Von Seggern, and M. Hallek Development of efficient viral vectors selective for vascular smooth muscle cells Mol Ther 9 2004 198 208 (Pubitemid 38256546)
159. L.M. Work, N. Ritchie, S.A. Nicklin, P.N. Reynolds, and A.H. Baker Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control Gene Ther 11 2004 1296 1300 (Pubitemid 39173437)
160. R.J. Yanez-Munoz, K.S. Balaggan, A. MacNeil, S.J. Howe, M. Schmidt, and A.J. Smith Effective gene therapy with nonintegrating lentiviral vectors Nat Med 12 2006 348 353 (Pubitemid 43355085)
161. Y. Yang, F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol, and J.M. Wilson Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proc Natl Acad Sci U S A 91 1994 4407 4411 (Pubitemid 24143442)
162. T. Zubilewicz, J. Wronski, A. Bourriez, P. Terlecki, A.M. Guinault, and B. Muscatelli-Groux Injury in vascular surgery-the intimal hyperplastic response Med Sci Monit 7 2001 316 324 (Pubitemid 32244817)
163. B.S. Zuckerbraun, and E. Tzeng Vascular gene therapy: a reality of the 21st century Arch Surg 137 2002 854 861 (Pubitemid 34743180)